Comparison of Efficacy and Safety of Vildagliptin and Linagliptin in Patients of Type 2 Diabetes Mellitus With Chronic Kidney Disease. Comm. Based Med J 2025, 14 (1), 96-100. https://doi.org/10.3329/cbmj.v14i1.79340.